Chapin Davis Inc. Takes Position in Aflac Incorporated (NYSE:AFL)

Chapin Davis Inc. acquired a new stake in Aflac Incorporated (NYSE:AFL) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 2,470 shares of the financial services provider’s stock, valued at approximately $221,000.

A number of other hedge funds also recently modified their holdings of AFL. International Assets Investment Management LLC lifted its stake in shares of Aflac by 8.6% during the 4th quarter. International Assets Investment Management LLC now owns 5,453 shares of the financial services provider’s stock worth $450,000 after buying an additional 433 shares during the last quarter. SVB Wealth LLC lifted its stake in shares of Aflac by 7.6% during the 4th quarter. SVB Wealth LLC now owns 11,156 shares of the financial services provider’s stock worth $920,000 after buying an additional 786 shares during the last quarter. Daiwa Securities Group Inc. lifted its stake in shares of Aflac by 6.3% during the 4th quarter. Daiwa Securities Group Inc. now owns 50,190 shares of the financial services provider’s stock worth $4,141,000 after buying an additional 2,992 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Aflac by 31.2% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 2,088 shares of the financial services provider’s stock worth $172,000 after buying an additional 497 shares during the last quarter. Finally, Federated Hermes Inc. lifted its stake in shares of Aflac by 163.2% during the 4th quarter. Federated Hermes Inc. now owns 16,613 shares of the financial services provider’s stock worth $1,371,000 after buying an additional 10,302 shares during the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Insider Activity at Aflac

In related news, Director Charles D. Lake II sold 22,378 shares of Aflac stock in a transaction that occurred on Tuesday, May 21st. The shares were sold at an average price of $87.47, for a total transaction of $1,957,403.66. Following the sale, the director now directly owns 61,522 shares of the company’s stock, valued at approximately $5,381,329.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the transaction, the director now owns 18,158 shares in the company, valued at $1,796,552.52. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Charles D. Lake II sold 22,378 shares of the stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $87.47, for a total value of $1,957,403.66. Following the sale, the director now owns 61,522 shares of the company’s stock, valued at $5,381,329.34. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by insiders.

Aflac Price Performance

Shares of NYSE:AFL opened at $105.17 on Monday. The firm has a 50 day moving average of $93.33 and a 200-day moving average of $86.89. The stock has a market capitalization of $59.76 billion, a PE ratio of 11.56, a PEG ratio of 2.76 and a beta of 0.95. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $72.78 and a 12 month high of $105.25.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.23. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $4.10 billion. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The firm’s revenue was down .7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.58 EPS. On average, equities research analysts predict that Aflac Incorporated will post 6.48 EPS for the current fiscal year.

Aflac Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, September 2nd. Investors of record on Wednesday, August 21st will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.90%. The ex-dividend date of this dividend is Wednesday, August 21st. Aflac’s dividend payout ratio (DPR) is presently 22.08%.

Analyst Upgrades and Downgrades

AFL has been the subject of a number of research reports. Piper Sandler raised their target price on shares of Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Friday, June 28th. Bank of America lifted their price objective on shares of Aflac from $105.00 to $108.00 and gave the stock a “buy” rating in a research note on Thursday, August 1st. Wells Fargo & Company lifted their price objective on shares of Aflac from $81.00 to $90.00 and gave the stock an “equal weight” rating in a research note on Monday, August 12th. JPMorgan Chase & Co. lifted their price objective on shares of Aflac from $80.00 to $83.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 2nd. Finally, Citigroup lifted their price objective on shares of Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 23rd. Two investment analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $90.62.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.